Interest Expense in USD of Vivos Therapeutics, Inc. from 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Vivos Therapeutics, Inc. quarterly/annual Interest Expense history and change rate from 2019 to Q3 2025.
  • Vivos Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2025 was $500K.
  • Vivos Therapeutics, Inc. annual Interest Expense for 2021 was $14K, a 85.4% decline from 2020.
  • Vivos Therapeutics, Inc. annual Interest Expense for 2020 was $96K, a 30.4% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Vivos Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $500K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-19
Q4 2021 $14K $4.18K -$13K -75.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $27K $9.49K -$7.5K -44.2% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $34.5K $251 -$17.8K -98.6% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $52.4K $82.00 -$43.6K -99.8% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $96K $17.2K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $17K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $18.1K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $43.7K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17

Vivos Therapeutics, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $14K -$82K -85.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $96K -$41.9K -30.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $138K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.